Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Atria Plc: SHARE REPURCHASE 21.4.2023

Atria Plc  ANNOUNCEMENT  21.4.2023 Atria Plc: SHARE REPURCHASE 21.4.2023 In the Helsinki Stock Exchange Trade date           21.4.2023Bourse trade         BuyShare                  ATRAVAmount             1 800 SharesAverage price/ share    12,1233 EURTotal cost            21 821,94 EUR Atria Plc now holds a total of 38 202 sharesincluding the shares repurchased on 21.4.2023 On behalf of Atria Plc Nordea Bank Oyj Janne Sarvikivi           Sami

Crown Energy updates its Financial Calendar

Crown Energy AB (publ) updates its financial calendar to allow for required reporting integrations related to the acquisition of SmarTee Sarl earlier this year.UPDATES TO THE FINANCIAL CALENDAR The new dates are:Annual Report 2022   April 30th 2023. Interim Report Q1 2023   May 29th 2023. Annual General Meeting 2023  June 1st 2023.   More information Contact person: Yoav Ben-Eli, CEO Crown Energy AB +46 76 312 9793   ABOUT CROWN ENERGY Crown Energy is an international group with a history within customised solutions for housing, offices and associated

Immunovia publishes the annual report for 2022

LUND, SWEDEN – Immunovia AB (publ) today announced that the Annual Report for 2022 has been published.  The annual report can be downloaded in pdf format and is available on Immunovia’s website: https://investor.immunovia.com/financial-reports/.      For more information, please contact: Karin Almqvist Liwendahl Chief Financial Officer karin.almqvist.liwendahl@immunovia.com +46 709 11 56 08   About ImmunoviaImmunovia is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for patients with cancer.

Kutsu Nitro Games Oyj:n Varsinaiseen Yhtiökokoukseen / Notice to the Annual General Meeting of Nitro Games Plc

Nitro Games Oyj:n osakkeenomistajat kutsutaan yhtiön varsinaiseen yhtiökokoukseen, joka pidetään 15.5.2023 klo 10.00 alkaen (Suomen aikaa) Nitro Games Oyj:n Kotkan toimipisteessä osoitteessa Juha Vainion katu 2, 48100 Kotka. Kokoukseen ilmoittautuneiden vastaanottaminen ja äänestyslippujen jakaminen aloitetaan klo 9.30. The shareholders of Nitro Games Plc are summoned to the company’s Annual General Meeting to be held on 15 May 2023 at 10.00 (Finnish time) at Nitro Games Plc’s Kotka office, Juha Vainion katu 2, 48100 Kotka, Finland. The reception of persons who have registered for the

The Supreme Administrative Court rejects JM’s application for leave to appeal

The Supreme Administrative Court announced on April 21, 2023, that it does not intend to hear the case between JM and Finansinspektionen with regard to JM’s annual report for 2017.In November 2022, the Administrative Court of Appeal announced its ruling that JM must consolidate tenant-owner associations in current production in its consolidated financial statements according to IFRS. JM chose to apply for leave to appeal with the Supreme Administrative Court. The decision by the Supreme Administrative Court to not grant leave to appeal thus closes the matter, and the ruling by the

#23-138 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#23-137 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Nel ASA: Annual General Meeting held in Nel ASA

(Oslo, 21 April 2023) The Annual general meeting of Nel ASA was held today. All proposals, except 9 and 11.1, set out in the notice to the general meeting were approved. As a result of the remuneration report not receiving sufficient support at the general meeting the company will take into consideration feedback from shareholders for the next report. Based on feedback from shareholders, changes done to the structure of the incentive programs are well received, but increased visibility on management KPI’s needs to be disclosed to document alignment between management incentives and

COMMUNIQUÉ FROM EXTRAORDINARY GENERAL MEETING IN PROSTATYPE GENOMICS AB (PUBL) HELD ON 21 APRIL 2023

Prostatype Genomics AB (publ), listed on the Nasdaq First North Growth Market, held an extraordinary general meeting today on 21 April 2023, whereby the following decisions were made. In accordance with previously published information, the board decided on a preferential share issue on 22 March 2023, subject to the subsequent approval of the extraordinary general meeting. The general meeting has today resolved to approve the board's decision on the preferential share issue in accordance with the below. · One (1) current share in Prostatype Genomics held on the record date on 25

Crunchfish Annual Report webinar

Crunchfish AB ("Crunchfish") Annual Report webinar is now available, where Crunchfish CEO Joachim Samuelsson is interviewed by analyst Johan Widmark from Emergers. The interview is in Swedish and covers the main events of the year and its progress.The webinar about Crunchfish Annual Report for 2022 is now available via the following link .   Crunchfish Annual Report for 2022 is available via the following link .   For more information, please contact: Joachim

S2Medical wins procurement for wound healing items in the United Arab Emirates worth approximately SEK 3.4 million

S2Medical AB (publ) (the "Company") has, via the Company's local partner in the United Arab Emirates, won a procurement for wound healing items within Mubadala Health LLC. The value of the procurement is estimated at approximately SEK 1.7 million per year for at least 2 years, a total of approximately SEK 3.4 million. Mubadala Health has announced that they intend to call off the procurement quarterly with orders corresponding to approximately SEK 400,000 - 500,000.   Mubadala Health is part of the Mubadala Investment Company and is one of the UAE's largest healthcare providers.

First section of Tokmanni’s new logistics centre now in operation – Centralizing Tokmanni’s logistics operations in Mäntsälä will modernise and streamline its logistics and supply chain

Tokmanni     Press release     21 April 2023 at 4:30 p.m. The new logistics centre currently under construction in Mäntsälä is a very significant investment for Tokmanni. It will help the company to modernise and streamline its logistics and supply chain. Lots of orange shelves. Long corridors. Dozens of Tokmanni employees and loads of lorries – including the familiar red Tokmanni lorries – are coming and going. The first section of Tokmanni’s new logistics centre has now been handed over by the contractor. The new centre, next door to Tokmanni’s existing administration and

Bulletin from the Annual General Meeting of John Mattson Fastighetsföretagen AB (publ)

At the annual general meeting (the “AGM”) of John Mattson Fastighetsföretagen AB (publ) held on 21 April 2023, the annual accounts for the financial year 2022 were adopted, it was resolved that no dividend shall be paid, the board members and CEO were discharged from liability for the 2022 financial year, it was resolved to amend the articles of association and the board of directors were authorised to issue shares.The AGM resolved not to distribute any dividend for the 2022 financial year and that the funds available for appropriation by the AGM, approximately SEK 1,833 million, be carried

Arctic Bioscience – Approval of share capital increase

Reference is made to the stock exchange release published by Arctic Bioscience earlier today 21 April 2023 regarding minutes from the Annual General Meeting.The Annual General Meeting resolved to increase the share capital from NOK 2 442 571,90 to NOK 2 536 955,20 by subscription of 943 833 new shares with a nominal value of NOK 0,10 per share, at a subscription price of NOK 17,27 per share, including a share premium of NOK 17,17 per share. The new shares shall be subscribed by Ronja Capital II AS and the subscription amount shall be settled by set off against the subscriber’s claim on

Epidemic Sound Artists Soundtrack the UN’s 17 Global Goals

· Epidemic Sound and Heart 17 continues partnership for the second consecutive year with the goal of spreading awareness around the UN’s 17 Global Goals · Today, on the UN World Creativity and Innovation Day, Epidemic Sound launches 17 songs for the Global Goals in partnership with the global initiative Heart 17 · To support and help raise awareness of the initiative, 19 Epidemic Sound artists, such as Ebo Krdum and Anna Landström, have created original tracks for the 17 Global GoalsStockholm, Sweden – Epidemic Sound, the market-leading music licensing platform for content creators,

Step into the House of AI at Berghs Festival 2023

Berghs School of Communication proudly announces “House of AI” to unite people and AI under one roof in a symbiotic relationship. It marks the return of the Student Agency after a four-year hiatus. This festival of ideas and creativity, created by a 12-member in-house agency, is set to take place on the 26th and 27th of May.[pressbild studentbyrn] First row from the left: Alva Saveby, Peyvand Ahmedi, William Andersson, Clara-Corina Imre, Charlotte Källström, Julia Löfqvist, Emma Schlyter, Li Wall, Noa Carle & Stella Nylén. Not in picture: Linn Berghagen Nilsson & Antonia Rösch.

Publication of Raute Corporation’s Q1 2023 Interim Report and invitation to a briefing

Raute Corporation, Investor news, 21 April 2023 Publication of Raute Corporation’s Q1 2023 Interim Report and invitation to a briefing   Raute Corporation will publish its Interim Report for January 1−March 31, 2023 (3 months) on Friday, April 28, 2023 at about 8 a.m. Finnish time. A briefing for analysts, investors and the media will be organized on the same day April 28, 2023 at 10:00−11:00 a.m.   Venue: Scandic Simonkentta Hotel, Simonkatu 9, Helsinki.   Please inform of your participation in the briefing at the latest on Wednesday, April 26, 2023 to Raute

Neste supplies sustainable aviation fuel to Air Canada for flights from San Francisco International Airport

Neste Corporation, News, 21 April 2023  Photo: courtesy of Air CanadaNeste and Air Canada are expanding their collaboration with an additional supply of 2.5 million gallons (9.5 million liters or 7,500 tons) of Neste MY Sustainable Aviation Fuel™ . The sustainable aviation fuel (SAF) supplied to Air Canada will be blended with conventional jet fuel and used to power the airline’s flights from the San Francisco International Airport.Air Canada has committed to the ambitious goal of net-zero emissions from all its global operations

Resqunit and Sig Hansen with a successful product demo in Norway - launching the product globally

On Thursday 20th April, Resqunit conducted a successful product demo during "One Ocean Week" in Bergen, Norway. The demo was made by major shareholder and the world's most famous fisherman and captain, Sig Hansen.STOCKHOLM, April 21, 2023, 14:30 CET - Resqunit AB (Nasdaq First North GM: RESQ) - We are very proud and satisfied to have carried out this exclusive product demo of our new product which is now being launched in several countries. The fight against ghost fishing has been going on for a long time, but with this product we can now begin to see the end. Our solution helps reduce a

GomSpace announces outcome of completed rights issue

GomSpace Group AB (publ) ("GomSpace" or the "Company") hereby announces the outcome of the rights issue of new shares resolved by the board of directors on 17 March 2023, with support of the authorisation from the annual general meeting held on 22 April 2022 (the "Rights Issue"). In total, 77,939,396 new shares, corresponding to approximately SEK 101 million or approximately 83 percent of the Rights Issue, have been subscribed for with and without subscription rights of which 41,225,646 new shares have been subscribed for against payment through set-off of the convertible loan of

GomSpace offentliggör utfall i genomförd företrädesemission

GomSpace Group AB (publ) (”GomSpace” eller ”Bolaget”) offentliggör härmed utfallet i den företrädesemission av nya aktier som beslutades av styrelsen den 17 mars 2023 med stöd av bemyndigande från årsstämman den 22 april 2022 (”Företrädesemissionen”). Totalt har 77 939 396 nya aktier, motsvarande cirka 101 MSEK eller cirka 83 procent av Företrädesemissionen, tecknats med och utan stöd av teckningsrätter varav 41 225 646 nya aktier har tecknats mot betalning genom kvittning av det konvertibla lånet om cirka 53,6 MSEK i enlighet med de teckningsåtaganden som beskrivs i det prospekt som

Immedica’s partner OrphanPacific initiates phase 3 trial with glycerol phenylbutyrate for treatment of urea cycle disorders in Japan

Stockholm, April 21 , 2023 - Immedica’s partner OrphanPacific Inc. (Tokyo, Japan) has enrolled the first patient in the phase 3 clinical trial with glycerol phenylbutyrate for the treatment of urea cycle disorders (UCD) in Japan. Immedica’s CEO Anders Edvell commented: “There is a significant medical need for better treatment options for people living with urea cycle disorders around the world. The initiation of this trial is a significant step towards expanding access to glycerol phenylbutyrate for patients in Japan.” This phase 3 clinical trial is planned to enroll 15 pediatric and

UNION therapeutics to participate at Kempen Life Science Conference

Hellerup, Denmark, April 21, 2023 – UNION therapeutics A/S (UNION), a privately-held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, today announced participation at the Kempen Life Science Conference on April 25-26, 2023, in Amsterdam.   Contacts Morten Boesen, Chief Financial Officer, UNION therapeutics A/S +45 2381 5487 morten.boesen@uniontherapeutics.com   Sarah Toft-Jørgensen, Director of Communications and IR, UNION therapeutics A/S +45 5385 3044 stj@uniontherapeutics.com   About UNION

There are no items matching the current filter
There are no more items matching the current filter
Back to top